High levels of tissue plasminogen activator (TPA) whose activity is regulated by serine protease inhibitor neuroserpin [45], has been associated with ASD [46, 47] and observed in the valproic acid model of autism [48]. This evidence concerns the gene SERPINI1 and autism.